La Trobe
- No file added yet -

Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

Download (5.49 MB)
journal contribution
posted on 2022-06-16, 04:26 authored by LK Billingham, JS Stoolman, K Vasan, AE Rodriguez, TA Poor, M Szibor, Howard JacobsHoward Jacobs, CR Reczek, A Rashidi, P Zhang, J Miska, NS Chandel
The NLRP3 inflammasome is linked to sterile and pathogen-dependent inflammation, and its dysregulation underlies many chronic diseases. Mitochondria have been implicated as regulators of the NLRP3 inflammasome through several mechanisms including generation of mitochondrial reactive oxygen species (ROS). Here, we report that mitochondrial electron transport chain (ETC) complex I, II, III and V inhibitors all prevent NLRP3 inflammasome activation. Ectopic expression of Saccharomyces cerevisiae NADH dehydrogenase (NDI1) or Ciona intestinalis alternative oxidase, which can complement the functional loss of mitochondrial complex I or III, respectively, without generation of ROS, rescued NLRP3 inflammasome activation in the absence of endogenous mitochondrial complex I or complex III function. Metabolomics revealed phosphocreatine (PCr), which can sustain ATP levels, as a common metabolite that is diminished by mitochondrial ETC inhibitors. PCr depletion decreased ATP levels and NLRP3 inflammasome activation. Thus, the mitochondrial ETC sustains NLRP3 inflammasome activation through PCr-dependent generation of ATP, but via a ROS-independent mechanism.

Funding

This work was supported by the National Institutes for Health (NIH) (5R35CA197532, 5P01HL071643-15 and 5PO1AG049665) to N.S.C.; L.K.B. was supported by the NIH/National Heart, Lung, and Blood Institute (NHLBI) (T32HL076139-15). J.M. was supported by the NIH (1R01NS115955-01). J.S.S. was supported by the NIH/National Institute of Allergy and Infectious Diseases (NIAID) T32 (T32AI083216). Additional support from the NIH (F30CA250236) to K.V., NIH/NHLBI T32HL076139-17 to T.A.P. and the Ford Foundation to A.E.R. We thank the Robert H. Lurie Cancer Center Flow Cytometry facility and Metabolomics Core supported by National Cancer Institute Cancer Center Support Grant (NCI CCSG) P30 CA060553 for their invaluable assistance. We thank P. Gao at Northwestern University for his expertise in metabolomics. We thank H. Abdala-Valencia at Northwestern University for RNA sequencing. We thank O. Grob at University of Freiburg for his helpful comments and discussion of the paper. Some figure elements were generated with biorender.com.

History

Publication Date

2022-05-01

Journal

Nature Immunology

Volume

23

Issue

5

Pagination

(p. 692-704)

Publisher

Springer Nature

ISSN

1529-2908

Rights Statement

© The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adap-tation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statu-tory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.